Part 3 of a 3-part HuMouse Series: An In Vivo CRS platform with Safety and Efficacy Applications

August 19, 2020

Join Rick Huntress and Dr. Basile Siewe on Wednesday, August 19 for the next episode of JAXLive! where they will discuss an in vivo CRS platform with both efficacy and safety applications.

Part 3 of a 3-part HuMouse Series: An In Vivo CRS platform with Safety and Efficacy Applications

Understanding Natural Killer Cells in Cancer Immunotherapies

Aged C57BL/6J Mice: Research Applications & Colony Management Considerations

A View on ALS Drug Discovery - Learnings From the Front Lines of Translational Disease Modeling

JAX Innovation: Where We See Preclinical Research Going

Model Generation Part 2: Building Complex Models and Embracing Genetic Diversity

JAXLive! Model Generation Part 1: An Introduction

Key Considerations for NASH Models

Part 2 of a 3-part Humanized Mouse Series: What to Consider When Humanizing an Immunodeficient Mouse

Part 1 of a 3-part HuMouse Series: Exploring JAX NSG Platform: Specialized Humanized Mouse Models

Modeling a Population: An Overview of JAX Diversity Outbred Mice

Tomorrow's Autoimmune Research Today: Mouse Models, Type 1 Diabetes, and More

JAXLive! A preview of Immunology Scientific Sessions -- CRS, NSG Mice, and More

JAX Live! Bispecific Antibody Testing

JAX LIVE! A Dialogue on Immunotoxicity and COVID-19-related CRS

T-cells, B-cells, macrophages: how to pick immunodeficient models

Ready, Set Go! Getting Back to Research After COVID-19

Taking CAR T Therapy for a Preclinical Test Drive

hACE2 Transgenic Model For COVID-19 Research

Respond and Recover: Risk Mitigation Through Cryopreservation

Using Autoimmune Disease Models in Pre-clinical Drug Discovery